Cholera Vaccines Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The global cholera vaccine market size in 2017 is $ 65 million and is projected to reach $207 million by 2027, growing at a CAGR of 15% from 2021 to 2027.

Cholera is one of the most prevalent infectious diseases caused by the bacteria Vibrio cholera. It can lead to death and causes severe diarrhea that requires immediate medical attention. According to the World Health Organization (WHO), nearly 21,000 to 1,43,000 people died of cholera worldwide in 2019. In addition, nearly 1.3 to 4 million cases of cholera are registered worldwide each year. Therefore, as the incidence of cholera increases, there will be significant demand for cholera vaccines over the expected period.

Market Segments

By Product

• Dukoral
• Shanchol
• Vaxchora
• Euvichol & Euvichol-Plus
• Others

By End-User

• Hospitals & clinics
• Research & Academic Laboratories
• Others

Key Players

• Valneva SE
• PaxVax, Inc.
• Astellas Pharma, Inc.
• Merck & Co., Inc.
• GlaxoSmithKline plc (GSK)
• Pfizer, Inc.
• Takeda Pharmaceutical Co., Ltd.
• Emergent BioSolutions, Inc.
• AstraZeneca

Scope of the Report

The research study analyzes the global Cholera Vaccines industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Cholera Vaccines Market Report

1. What was the Cholera Vaccines Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Cholera Vaccines Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Cholera Vaccines Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.